Genknowme raises CHF 500,000

Genknowme offers epigenetic blood tests that measure biological age and the impact of chronic stress, now reimbursed by the insurer KPT. The start-up raised CHF 500,000 earlier this year from an unnamed strategic investor.

Announced on
Round
Undisclosed round
Amount
CHF 500,000
Location
Lausanne, canton of Vaud
Sector
Health & medtech

Investors

The investors were not named in the announcement.

Preparing a similar round?

The diagnostic shows you the instruments and investors that fit your stage.

Start the diagnostic